First American Bank Gilead Sciences, Inc. Transaction History

First American Bank

$1.39 Trillion
Q3 2024

A detailed history of First American Bank transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, First American Bank holds 29,800 shares of GILD stock, worth $2.67 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

29,800

Previous 30,209 1.35%

Holding current value

$2.67 Million

Previous $2.07 Billion 20.54%

% of portfolio

0.18%

Previous 0.16%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$66.59 - $83.99 $27,235 - $34,351	-409 Reduced 1.35%	29,800 $2.5 Billion
Q2 2024 Jul 30, 2024	SELL	$63.15 - $72.88 $29,364 - $33,889	-465 Reduced 1.52%	30,209 $2.07 Billion
Q4 2023 Jul 31, 2024	SELL	$73.27 - $83.09 $23,812 - $27,004	-325 Reduced 1.06%	30,209 $2.45 Million
Q3 2023 Jul 31, 2024	BUY	$73.94 - $80.67 $29,280 - $31,945	396 Added 1.31%	30,534 $2.29 Million
Q1 2023 Jul 31, 2024	SELL	$77.31 - $88.08 $41,360 - $47,122	-535 Reduced 1.74%	30,138 $2.5 Million
Q4 2022 Jul 31, 2024	BUY	$62.32 - $89.47 $6,294 - $9,036	101 Added 0.33%	30,673 $2.63 Million
Q3 2022 Jul 31, 2024	BUY	$59.54 - $68.01 $7,859 - $8,977	132 Added 0.43%	30,572 $1.89 Million
Q2 2022 Jul 31, 2024	SELL	$57.72 - $65.01 $13,506 - $15,212	-234 Reduced 0.76%	30,440 $1.88 Million
Q1 2022 Jul 31, 2024	BUY	$57.92 - $72.58 $26,932 - $33,749	465 Added 1.54%	30,674 $1.82 Million
Q3 2021 Oct 28, 2021	SELL	$67.69 - $73.03 $50,090 - $54,042	-740 Reduced 2.36%	30,674 $2.14 Million
Q2 2021 Jul 13, 2021	SELL	$63.47 - $69.35 $21,262 - $23,232	-335 Reduced 1.06%	31,414 $2.16 Million
Q1 2021 Apr 08, 2021	SELL	$60.0 - $68.46 $15,660 - $17,868	-261 Reduced 0.82%	31,749 $2.05 Million
Q4 2020 Jan 06, 2021	SELL	$56.65 - $64.55 $900,904 - $1.03 Million	-15,903 Reduced 33.19%	32,010 $1.87 Million
Q3 2020 Oct 09, 2020	SELL	$62.1 - $78.08 $1,242 - $1,561	-20 Reduced 0.04%	47,913 $3.03 Million
Q1 2020 Apr 07, 2020	SELL	$62.63 - $80.22 $1.34 Million - $1.72 Million	-21,405 Reduced 30.87%	47,933 $3.58 Million
Q4 2019 Jan 24, 2020	BUY	$61.62 - $67.78 $4.27 Million - $4.7 Million	69,338 New	69,338 $4.51 Million

Others Institutions Holding GILD

# of Institutions

1,924

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First American Bank, based on Form 13F filings with the SEC.

News

Stay updated on First American Bank with notifications on news.

Account

First American Bank Gilead Sciences, Inc. Transaction History